Compare LYEL & HBNC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | LYEL | HBNC |
|---|---|---|
| Founded | 2018 | 1873 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 745.5M | 883.5M |
| IPO Year | 2021 | N/A |
| Metric | LYEL | HBNC |
|---|---|---|
| Price | $23.39 | $17.66 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 3 | 3 |
| Target Price | ★ $25.00 | $19.67 |
| AVG Volume (30 Days) | 133.6K | ★ 398.2K |
| Earning Date | 11-12-2025 | 01-21-2026 |
| Dividend Yield | N/A | ★ 3.69% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $41,000.00 | N/A |
| Revenue This Year | N/A | $51.78 |
| Revenue Next Year | N/A | $7.75 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 1.91 |
| 52 Week Low | $7.65 | $12.70 |
| 52 Week High | $45.00 | $18.70 |
| Indicator | LYEL | HBNC |
|---|---|---|
| Relative Strength Index (RSI) | 35.79 | 58.05 |
| Support Level | $22.75 | $16.82 |
| Resistance Level | $25.12 | $17.34 |
| Average True Range (ATR) | 2.58 | 0.43 |
| MACD | -1.30 | 0.00 |
| Stochastic Oscillator | 3.85 | 88.32 |
Lyell Immunopharma Inc is a clinical-stage cell therapy company. It has a pipeline of product candidates for patients with solid tumors utilizing ex vivo genetic and epigenetic T-cell reprogramming technologies. The company's product pipeline includes, LYL797, LYL119, LYL845 among others.
Horizon Bancorp (IN) is a United States-based holding company providing banking services. It is engaged in providing commercial and retail banking services, corporate and individual trust and agency services, and other services incident to banking. The company also provides commercial loans, real estate loans, mortgage warehouse loans, consumer loans, and other credit facilities. The company has one principal business segment, commercial banking.